After IL-2 stimulation, the activated patient NK cells revealed improved distribution of increased immunoregulatory NK cells (CD56bright/CD16dim&neg), enhanced TNFα and IFN-γ secretion and up-regulated NKG2D expression levels that resulted in enhanced cytotoxicity against associated HNSCC cells. The gene discussed is IL2; the disease is head and neck squamous cell carcinoma.